Bioteque Corporation (TPEX:4107)

Market Cap	8.14B -10.0%
Revenue (ttm)	2.14B +3.0%
Net Income	539.19M +2.1%
EPS	7.74 +2.0%
Shares Out	69.30M
PE Ratio	15.18
Forward PE	14.47
Dividend	5.50 (4.68%)
Ex-Dividend Date	Jul 28, 2025

Volume	62,819
Average Volume	54,973
Open	117.00
Previous Close	118.00
Day's Range	116.50 - 118.00
52-Week Range	101.00 - 132.00
Beta	0.14
RSI	42.21
Earnings Date	Mar 12, 2026

About Bioteque

Bioteque Corporation manufactures and sells medical device in Asia, South America, North America, and internationally. The company provides medical disposables for use in hemodialysis access, endovascular treatment, and other fields. It offers dialysis products, including hemodialysis bloodlines, A.V.F. needles, and hemodialysis cathers; interventional radiology products, such as pigtail drainage catheter sets, introducer sets, connecting tubes, drainage bags, and radiopaque dilators; urology products comprising ureteral stent sets and urine co...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4107

Financial Performance

In 2025, Bioteque's revenue was 2.14 billion, an increase of 3.03% compared to the previous year's 2.07 billion. Earnings were 539.19 million, an increase of 2.07%.